Nagoba Basavraj S, Dhotre Shree V, Gavkare Ajay M, Mumbre Sachin S, Dhotre Pradnya S
Department of Microbiology, Maharashtra Institute of Medical Sciences and Research (Medical College), Latur 413531, India.
Department of Microbiology, Ashwini Rural Medical College, Solapur 413001, India.
World J Virol. 2025 Mar 25;14(1):99904. doi: 10.5501/wjv.v14.i1.99904.
This editorial comments on the article by Desai , which investigates the impact of coronavirus disease 2019 (COVID-19) on in-hospital mortality among patients with recurrent stroke using data from the 2020 National Inpatient Sample. The findings reveal significantly higher mortality rates in COVID-19-positive patients compared to non-COVID-19 patients, particularly among middle-aged individuals, males, and ethnic minorities. This editorial explores the underlying mechanisms contributing to these outcomes and discusses the clinical implications for targeted management strategies in high-risk groups. The results emphasize the need for comprehensive approaches to mitigate the heightened risks faced by recurrent stroke patients during the COVID-19 pandemic.
本社论对德赛的文章进行评论,该文章利用2020年全国住院患者样本数据,研究了2019冠状病毒病(COVID-19)对复发性中风患者院内死亡率的影响。研究结果显示,与非COVID-19患者相比,COVID-19阳性患者的死亡率显著更高,尤其是在中年个体、男性和少数族裔中。本社论探讨了导致这些结果的潜在机制,并讨论了针对高危人群的管理策略的临床意义。结果强调,需要采取综合方法来减轻COVID-19大流行期间复发性中风患者面临的更高风险。